(Q40435814)

20 September 2017

1 reference

title

Tumor imaging with monoclonal antibodies (English)

1 reference

20 September 2017

Bischof Delaloye A

1

1 reference

20 September 2017

Delaloye B

series ordinal

2

1 reference

20 September 2017

publication date

1 April 1995

1 reference

Seminars in Nuclear Medicine

20 September 2017

published in

1 reference

20 September 2017

volume

25

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

144-164

1 reference

In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Radioimmunolocalization of Tumours by External Scintigraphy after Administration of131I Antibody to Human Chorionic Gonadotrophin: Preliminary Communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Uptake of radiolabeled anti-CEA antibodies in human colorectal primary tumors as a function of tumor mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine-labelled antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Continuous cultures of fused cells secreting antibody of predefined specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Comparative imaging and biodistribution studies with an anti-CEA monoclonal antibody and its F(ab)2 and Fab fragments in mice with colon carcinoma xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

A prospective study of the use of 111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

99mTc-labeled monoclonal anti-carcinoembryonic antigen antibody (BW 431/26). Clinical results in the detection of colorectal carcinomas and recurrences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

The preparation and labeling of DTPA-coupled albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

European multicentre study on melanoma immunoscintigraphy by means of 99mTc-labelled monoclonal antibody fragments. The European Multicentre Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. I. The effect on image contrast in clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

A comparison of iodine and indium labelled anti CEA intact antibody, F(ab)2 and Fab fragments by imaging tumour xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Radioimmunoscintigraphy with 111In labelled monoclonal antibody fragments (F(ab')2 BW 431/31) against CEA: radiolabelling, antibody kinetics and distribution, findings in tumour and non-tumour patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Clinical value of radioimmunoscintigraphy in the follow-up of ovarian carcinoma: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Enhanced kidney clearance with an ester-linked 99mTc-radiolabeled antibody Fab'-chelator conjugate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Decreased kidney uptake of technetium-99m-labelled Fab' fragments in ovarian carcinoma bearing nude mice using a cleavable chelator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Synthesis and evaluation of two new bifunctional carboxymethylated tetraazamacrocyclic chelating agents for protein labeling with indium-111

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Immunoscintigraphy with biosynthetically-labeled 75Se-antibodies--II. Comparison with antibodies labeled by radioiodination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Correlative imaging study in the diagnosis of ovarian cancer recurrences. The INSERM Research Network (Nantes, Rennes, Reims, Villejuif, Saclay), France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Superimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Intraperitoneal 131I- and 111In-791T/36 monoclonal antibody in recurrent ovarian cancer: imaging and biodistribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Immunoscintigraphy using different methods of applying a 99mTc labeled monoclonal anti-CEA-antibody in the staging of patients with liver metastases before partial hepatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Immunoscintigraphy for detection of lymph node metastases from breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

[Immunolymphoscintigraphy. A new procedure for noninvasive lymph node staging illustrated by the example of breast cancer]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Lymphoscintigraphy with 13I-labelled epidermal growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Liposomally entrapped second antibody improves tumour imaging with radiolabelled (first) antitumour antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

AVIDIN. 1. THE USE OF (14-C)BIOTIN FOR KINETIC STUDIES AND FOR ASSAY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Pre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99mTc]PnAO-biotin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Preparation of bispecific antibodies by chemical recombination of monoclonal immunoglobulin G1 fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Hybrid hybridomas and their use in immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Development of a bispecific monoclonal antibody against a gallium-67 chelate and the human melanoma-associated antigen p97 for potential use in pretargeted immunoscintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Immunoscintigraphy of colorectal cancer with an antibody to epithelial membrane antigen (EMA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Anti-CEA and other antibodies in the study of gastrointestinal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Radioimmunoscintigraphy of colorectal carcinoma with a 99Tcm-labelled anti-CEA monoclonal antibody (BW 431/26)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Radioimmunoscintigraphy of colorectal carcinoma with a 111In-labelled anti-TAG-72 monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer: preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

A prospective evaluation of OC125 and magnetic resonance imaging in patients with ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Immunoscintigraphy of ovarian carcinoma using a monoclonal antibody (111In-NCRC48) defining a polymorphic epithelial mucin (PEM) epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Radioimmunodetection of melanoma: preliminary results of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Immunoscintigraphy in intraocular malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Radioimmunoscintigraphy and immunohistochemistry with melanoma-associated monoclonal antibodies in choroidal melanoma: a comparison of the clinical and immunohistochemical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Anti-melanoma antibodies bind preferentially to diploid metastases in immunoscintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Immunoscintigraphy in malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Neuroblastoma imaged with 123I meta-iodo-benzylguanidine and with 123I-labelled monoclonal antibody, UJ13A, against neural tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Immunoscintigraphy of human lung squamous cell carcinoma using an iodine-131 labelled monoclonal antibody (Po66).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

99mTc-anti-CEA radioimmunoscintigraphy of lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Quantitative measurement of monoclonal antibody distribution and blood flow using positron emission tomography and124iodine in patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Antibody targeting to the murine lymphoma ESb-MP: increased accumulation due to reduced internalization into lymphoma cells as compared to normal lymphoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Preferential antibody targeting to small lymphoma metastases in the absence of the primary tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Initial clinical results with technetium-99m-labeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Anti-murine antibody response to mouse monoclonal antibodies: clinical findings and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Toxicity associated with the formation and clearance of immune complexes between antitumour monoclonal antibodies and syngeneic anti-idiotypic antibodies in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Generation of a recombinant mouse-human chimaeric monoclonal antibody directed against human carcinoembryonic antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Different behaviour of mouse-human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub-classin vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Tumour localisation with 131I-labelled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Reshaping human antibodies for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Engineering monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2895%2980023-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-2998(95)80023-9

1 reference

20 September 2017

1 reference